Pharmaceutical Excipient Compliance Knowledge Base
Practical guides for excipient suppliers covering EXCiPACT, DMF, quality agreements, risk assessment and traceability.
Back to excipients industry hubAll Practical Guides
This topic index gathers all practical guides for the segment, organised around common customer questions.
EXCiPACT Pharmaceutical Excipient GMP/GDP QMS Setup & Audit Prep
Detailed review of EXCiPACT excipient GMP/GDP certification, guiding sites through clean area zoning, batch clearance logs, and audit prep.
US & China Pharmaceutical Excipient DMF Registration & Joint Review Guide
Analyzing U.S. FDA Type IV DMF and China CDE registration pathways for excipients, guiding CTD Module 3 compilation for drug-excipient joint reviews.
Pharmaceutical Excipient Quality Agreement Formulation & Clause Guide
Guiding excipient manufacturers to draft and negotiate Quality Agreements per IPEC rules, detailing change notification windows and audit access.
Co-processed Excipients International Regulatory & Filing Guidelines
Interpreting co-processed excipients definitions, process validation, toxicological safety assessment, and DMF submissions to FDA/NMPA.
Excipient Supplier Risk Classification & Quality Audit Strategy
Introducing how pharmaceutical manufacturers classify excipient suppliers based on use (sterile, oral, topical), supplier systems, and raw material risk.
Pharmaceutical Excipient Functionality-Related Characteristics (FRCs)
Introducing FRCs defined in USP/EP, physical testing methods (particle size, porosity, BET surface area), and their impact on tablet quality.
Pharmaceutical Excipient Distribution Supply Chain Traceability Rules
Introducing IPEC-PQG GMP/GDP rules for pharmaceutical excipients during distribution, split packaging, relabeling, and label reprint controls.
Pharmaceutical Excipient Warehouse Management & GDP (GWP) Audit Focus
Systematic overview of Good Warehousing Practices (GWP) for excipients, covering temperature mapping, status labeling, and audit checklists.
Pharmaceutical Excipient Residual Solvents (ICH Q3C) & Impurity Controls
Systematic guide to IPEC guidelines for excipient residual solvent risk assessments and declarations, utilizing GC Headspace methods.
Pharmaceutical Excipient Microbial Limits & Objectionable Pathogens Control
Analyzing microbial limits (TAMC/TYMC) for excipients used in sterile and non-sterile drug formulations, pathogen screens, and mycotoxin reviews.
